Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 195 of 6351
-
Can a Needle-Free prostate treatment match implant surgery?
Disease control Recruiting nowThis clinical trial aims to determine whether Prolieve® (microwave with balloon dilation) is as effective as UroLift® (prostate implants) for treating moderate-to-severe lower urinary tract symptoms in men aged 50-80 with enlarged prostates (BPH) who have failed oral medications.…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a shorter hormone course plus precision radiation curb prostate cancer spread?
Disease control Recruiting nowFor this study, high risk prostate cancer patients with lower risk ARTERA scores will be treated with 6 months of Androgen Deprivation Therapy (ADT) in conjunction with dose escalated radiotherapy to the prostate and nodes. Specifically, patients enrolled in this study will under…
Phase 2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Can a smart drug deliver a toxic payload to prostate cancer cells?
Disease control Recruiting nowThe purpose of Part 1 of this study is to find out how safe JNJ-98768111 is and the most suitable dose (recommended phase 2 dose \[RP2D\]) regimen(s) of JNJ-98768111. The purpose of Part 2 of this study is to find out how safe JNJ-98768111 is at the RP2D regimen(s) in participant…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a new injection help shed excess weight?
Disease control Recruiting nowThe purpose of this clinical study is to look at how well a study medicine called cagrilintide helps people living with excess body weight to lose weight. Participants will either get cagrilintide, the active study medicine being tested or placebo, a medicine that has no active m…
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new injection help shed pounds? a trial investigates
Disease control Recruiting nowObesity is a condition where a person has excessive body fat, defined by a body mass index (BMI) of 30 kg/m2 or higher. The goal of this study is to evaluate the effect of various doses of ABBV-295 compared to placebo on reducing body weight at Week 32 in participants with obesit…
Phase 2 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Can Direct-to-Abdomen chemotherapy tame GI cancers that spread?
Disease control Recruiting nowThis is a phase II open-label, basket clinical trial to assess the feasibility of systemic and Intraperitoneal chemotherapy in subjects with Gastrointestinal Malignancies with Peritoneal Carcinomatosis. These are subjects who have a proven primary carcinoma of the digestive tract…
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New ointment aims to restore skin color in vitiligo
Disease control Recruiting nowThis is a randomized, double-blind, multicenter, placebo-controlled clinical study intended to evaluate the efficacy, safety and population pharmacokinetic profiles of MH004 ointment in eligible participants with NSV.
Phase 3 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Weight-loss drug ecnoglutide takes aim at knee osteoarthritis pain
Symptom relief Recruiting nowThe main purpose of the study is to evaluate the efficacy and safety of ecnoglutide injections versus placebo in obese participants with KOA.
Phase 3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Can a new eye injection beat the current standard for diabetic vision loss?
Disease control Recruiting nowA Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants with Diabetic Macular Edema - ALTO
Phase 3 • Sponsor: Kodiak Sciences Inc • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can tiny electric acupuncture needles help women with low egg reserve conceive?
Disease control Not yet recruitingThe goal of this clinical trial is to examine the effect of ETN on live birth rate in patients with diminished ovarian reserve (DOR) undergoing in vitro fertilizitaion-embryo transfer (IVF-ET). Four hundred and six patients with DOR will be enrolled randomly divided into treatmen…
Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a Two-Drug attack shrink recurrent throat cancer?
Disease control Recruiting nowThis study plans to enroll patients with histologically or cytologically confirmed locally recurrent nasopharyngeal carcinoma. After signing informed consent, eligible subjects will receive three cycles of standard-dose becotatug vedotin combined with a PD-1 inhibitor. Following …
Phase 2 • Sponsor: Hongmeng Yu • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a robotic suit restore walking after stroke or spinal injury?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether the ZEPU AI9 lower limb exoskeleton robot is feasible, safe, and effective for people with walking difficulty caused by stroke, incomplete spinal cord injury, or orthopedic surgery. The main questions it aims to answer are: Is …
Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a lower dose of radiation plus a targeted pill treat this lymphoma just as well?
Disease control Not yet recruitingMulti center, randomized, controlled, prospective clinical trial to explore the clinical efficacy and safety of low-dose radiotherapy combined with targeted therapy for localized MALT lymphoma.
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
A steroid-sparing strategy for IgG4-related disease: lenalidomide put to the test
Disease control Not yet recruitingImmunoglobulin G4-related disease (IgG4-RD) is a chronic immune-mediated disorder characterized by inflammation, fibrosis, and involvement of multiple organs. Although glucocorticoids can effectively induce remission, many patients experience disease relapse after glucocorticoid …
Phase 3 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a natural compound boost chemotherapy against endometrial cancer?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if Elemene Liposomes, combined with carboplatin and paclitaxel (TC) chemotherapy can improve prognosis in patients with advanced or recurrent endometrial cancer. The main question it aims to answer is: Does adding Elemene Liposomes to …
Phase 2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a Dual-Action drug combo outsmart advanced liver cancer?
Disease control Not yet recruitingThis clinical study aims to evaluate the efficacy and safety of Retlirafusp alfa Injection (SHR-1701) combined with apatinib in patients with advanced hepatocellular carcinoma (HCC) who have experienced disease progression after first-line targeted combined immunotherapy, and pro…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a pill replace an IV for advanced breast cancer treatment?
Disease control Not yet recruitingThis study is a randomized controlled study.The primary objective is to evaluate the Progression-Free Survival(PFS) of Utidelone Capsule combined with Capecitabine compared with Utidelone Injection combined with Capecitabine in patients with HER-2 negative advanced breast cancer.
Phase 3 • Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a new injection ease COPD and cut Flare-Ups?
Disease control Not yet recruitingThe main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximat…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a blood test and MRI tailor cancer therapy to each patient?
Disease control Recruiting nowThis study aims to explore the efficacy and safety of risk-adapted adjuvant therapy based on dynamic EBV-DNA changes and MRI in nasopharyngeal carcinoma patients.
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new pill outsmart resistant breast cancer?
Disease control Recruiting nowThis is a multicenter, open-label, Phase 2 bridging study to evaluate the efficacy and safety of elacestrant in Japanese post-menopausal women and men with estrogen receptor positive (ER+)/human epidermal growth factor receptor 2 negative (HER2-) advanced or metastatic breast can…
Phase 2 • Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC